Literature DB >> 16525566

Haemostasis and pregnancy.

Massimo Franchini1.   

Abstract

Normal pregnancy is associated with profound alterations in the coagulation and fibrinolytic systems. While these physiological procoagulant changes are aimed to minimise intrapartum blood loss, they do increase the risk of thromboembolism during pregnancy and the post-partum period. In contrast and more rarely, haemorrhage due to an underlying inherited or acquired bleeding disorder may occur and complicate a pregnancy. Based on an analysis of the literature data, this review presents an overview of the main thrombotic and haemorrhagic disorders complicating pregnancy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16525566     DOI: 10.1160/TH05-11-0753

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  24 in total

Review 1.  Risk factors for venous and arterial thrombosis.

Authors:  Emanuele Previtali; Paolo Bucciarelli; Serena M Passamonti; Ida Martinelli
Journal:  Blood Transfus       Date:  2010-10-25       Impact factor: 3.443

2.  Changes in blood parameters and the expression of coagulation-related genes in lactating Sprague-Dawley rats.

Authors:  Yoshinaka Urasoko; Xi Jun He; Takano Masao; Yuichi Kinoshita; Hiroshi Edamoto; Kazuhisa Hatayama; Yuzo Asano; Kazutoshi Tamura; Masahiro Mochizuki
Journal:  J Am Assoc Lab Anim Sci       Date:  2012-03       Impact factor: 1.232

3.  The cost-benefit ratio of screening pregnant women for thrombophilia.

Authors:  Gian Luca Salvagno; Giuseppe Lippi; Massimo Franchini; Giovanni Targher; Martina Montagnana; Massimo Franchi; Gian Cesare Guidi
Journal:  Blood Transfus       Date:  2007-11       Impact factor: 3.443

4.  Antiphospholipid Syndrome during pregnancy: the state of the art.

Authors:  Fosca A F Di Prima; Oriana Valenti; Entela Hyseni; Elsa Giorgio; Marianna Faraci; Eliana Renda; Roberta De Domenico; Santo Monte
Journal:  J Prenat Med       Date:  2011-04

5.  Thrombin generation test as a marker for high risk venous thrombosis pregnancies.

Authors:  Bérangère S Joly; Bénédicte Sudrié-Arnaud; Virginie Barbay; Jeanne-Yvonne Borg; Véronique Le Cam Duchez
Journal:  J Thromb Thrombolysis       Date:  2018-01       Impact factor: 2.300

6.  High frequency of decreased antithrombin level in pregnant women with thrombosis.

Authors:  Yuki Kamimoto; Hideo Wada; Makoto Ikejiri; Kaname Nakatani; Takashi Sugiyama; Kazuhiro Osato; Nao Murabayashi; Norikazu Yamada; Takeshi Matsumoto; Kohshi Ohishi; Hidehiro Ishikawa; Hidekazu Tomimoto; Masaaki Ito; Tomoaki Ikeda
Journal:  Int J Hematol       Date:  2015-07-02       Impact factor: 2.490

Review 7.  Pregnancy outcomes of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab: a Japanese experience and updated review.

Authors:  Naoyuki Miyasaka; Osamu Miura; Tatsuya Kawaguchi; Nobuyoshi Arima; Eriko Morishita; Kensuke Usuki; Yasuyoshi Morita; Kaichi Nishiwaki; Haruhiko Ninomiya; Akihiko Gotoh; Shinsaku Imashuku; Akio Urabe; Tsutomu Shichishima; Jun-Ichi Nishimura; Yuzuru Kanakura
Journal:  Int J Hematol       Date:  2016-02-08       Impact factor: 2.490

8.  Postpartum cardiomyopathy: a cardiac emergency for gynecologists, general practitioners, internists, pulmonologists, and cardiologists.

Authors:  Denise Hilfiker-Kleiner; Elisabeth Schieffer; Gerd Peter Meyer; Edith Podewski; Helmut Drexler
Journal:  Dtsch Arztebl Int       Date:  2008-10-31       Impact factor: 5.594

9.  Extracorporeal Treatment for the Acute und Long-Term Outcome of Patients with Life-Threatening Acquired Hemophilia.

Authors:  Heike Zeitler; Gudrun Ulrich-Merzenich; Darius Panek; Georg Goldmann; Natascha Vidovic; Hans-Hermann Brackmann; Johannes Oldenburg
Journal:  Transfus Med Hemother       Date:  2012-07-26       Impact factor: 3.747

10.  Anaesthesia for Caesarean Section of Pregnant Women with Idiopathic Thrombocytopenic Purpura.

Authors:  Şule Özbilgin; Bahar Kuvaki Balkan; Belkıs Şaşmaz
Journal:  Turk J Anaesthesiol Reanim       Date:  2013-04-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.